CRG to provide $200 mln debt facility to Harmony

CR Group LP has agreed to provide a $200 million debt facility to Plymouth Meeting, Pennsylvania-based Harmony Biosciences LLC, a biopharmaceutical company. The capital infusion will be used as working capital for Harmony's continued growth. Octagon Capital Group and Katten Muchin Rosenman advised Harmony on the transaction while Cooley advised CRG.

North AmericaUSHealthcareCreditBriefs